Related Experiment Videos
["Targeted delivery" in the gastrointestinal tract]
1Institut für Pharmazeutische Technologie, Heinrich-Heine-Universität Düsseldorf. leopold@uni-duesseldorf.deoder
Medizinische Klinik (Munich, Germany : 1983)
|April 9, 1999
Summary
Researchers are exploring colon-specific drug delivery, particularly for peptide drugs and colonic diseases. Key strategies leverage pH differences, enzymatic activity, transit time, and pressure changes for targeted intestinal delivery.
Area of Science:
- Gastroenterology and Drug Delivery
- Pharmacology and Therapeutics
Context:
- Intestinal drug delivery is gaining traction for treating colonic diseases and delivering peptide therapeutics.
- Targeting the colon requires overcoming physiological barriers and achieving site-specific release.
Purpose:
- To review and outline strategies for achieving colon-specific drug delivery.
- To highlight methods for enhancing the efficacy of intestinal drug formulations.
Summary:
- Four primary strategies are employed for colon specificity: exploiting pH gradients, utilizing colonic microflora enzymatic activity, relying on small intestinal transit time, and leveraging increased colonic luminal pressure.
- pH-controlled and time-controlled release mechanisms facilitate drug delivery to the small intestine.
- Diffusion-controlled systems enable drug delivery throughout the entire gastrointestinal tract.
Impact:
- Informs the development of advanced drug delivery systems for gastrointestinal disorders.
- Provides a foundation for optimizing therapeutic outcomes through targeted intestinal drug administration.